The protective effects of aloperine against ox-LDL-induced endothelial dysfunction and inflammation in HUVECs

References

• Gimbrone MA, Jr, García-Cardeña G. Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ Res. 2016;118(4):620–636.
   PubMed Web of Science ®Google Scholar
• Daiber A, Steven S, Weber A, et al. Targeting vascular (endothelial) dysfunction. Br J Pharmacol. 2017;174(12):1591–1619.
   PubMed Web of Science ®Google Scholar
• Tousoulis D, Oikonomou E, Economou EK, et al. Inflammatory cytokines in atherosclerosis: current therapeutic approaches. Eur Heart J. 2016;37(22):1723–1732.
   PubMed Web of Science ®Google Scholar
• Kattoor AJ, Pothineni NV, Palagiri D, et al. Oxidative stress in atherosclerosis. Curr Atheroscler Rep. 2017;19(11):42.
   PubMed Web of Science ®Google Scholar
• Siegel D, Ross D. Immunodetection of NAD (P) H: quinone oxidoreductase 1 (NQO1) in human tissues. Free Radic Biol Med. 2000;29(3–4):246–253.
   PubMed Web of Science ®Google Scholar
• Kanikarla-Marie P, Jain SK. 1, 25 (OH) 2D3 inhibits oxidative stress and monocyte adhesion by mediating the upregulation of GCLC and GSH in endothelial cells treated with acetoacetate (ketosis). J Steroid Biochem Mol Biol. 2016;159:94–101.
   PubMed Web of Science ®Google Scholar
• Mitra S, Goyal T, Mehta JL. Oxidized LDL, LOX-1 and atherosclerosis. Cardiovasc Drugs Ther. 2011;25(5):419.
   PubMed Web of Science ®Google Scholar
• Pirillo A, Norata GD, Catapano AL. LOX-1, OxLDL, and atherosclerosis. Mediators Inflamm. 2013;2013:1.
   Web of Science ®Google Scholar
• Seino Y, Ikeda U, Ikeda M, et al. Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions. Cytokine. 1994;6(1):87–91.
   PubMed Web of Science ®Google Scholar
• Kasashima S, Kawashima A, Zen Y, et al. Upregulated interleukins (IL-6, IL-10, and IL-13) in immunoglobulin G4-related aortic aneurysm patients. J Vasc Surg. 2018;67(4):1248–1262.
   PubMed Web of Science ®Google Scholar
• Hsu DC, Yi Fei MA, Sophia HU, et al. Plasma IL-6 levels are independently associated with atherosclerosis and mortality in HIV-infected individuals on suppressive ART. AIDS (London, England). 2016;30(13):2065.
   PubMed Web of Science ®Google Scholar
• Drechsler M, Duchene J, Soehnlein O. Chemokines control mobilization, recruitment, and fate of monocytes in atherosclerosis. Arterioscler Thromb Vasc Biol. 2015;35(5):1050–1055.
   PubMed Web of Science ®Google Scholar
• Masseau I, Bowles DK. Carotid endothelial VCAM-1 is an early marker of carotid atherosclerosis and predicts coronary artery disease in swine. JBiSE. 2015;08 (11):767.
   Google Scholar
• Tsoref O, Amit U, Landa N, et al. E-selectin-targeted novel nano polymers stabilize atherosclerotic plaque and improve cardiac remodeling. Circulation. 2016;134(suppl_1):A14013.
   Google Scholar
• Khodabandehlou K, Masehi-Lano JJ, Poon C, et al. Targeting cell adhesion molecules with nanoparticles using in vivo and flow-based in vitro models of atherosclerosis. Exp Biol Med (Maywood). 2017;242(8):799–812.
   PubMed Web of Science ®Google Scholar
• Wang Y, Sun M, Wang Z, et al. Omentin-1 ameliorates the attachment of the leukocyte THP-1 cells to HUVECs by targeting the transcriptional factor KLF2. Biochem Biophys Res Commun. 2018;498(1):152–156.
   PubMed Web of Science ®Google Scholar
• SenBanerjee S, Lin Z, Atkins GB, et al. KLF2 Is a novel transcriptional regulator of endothelial proinflammatory activation. J Exp Med. 2004;199(10):1305–1315.
   PubMed Web of Science ®Google Scholar
• Di X, Tang X, Di X. Montelukast inhibits oxidized low-density lipoproteins (ox-LDL) induced vascular endothelial attachment: an implication for the treatment of atherosclerosis. Biochem Biophys Res Commun. 2017;486(1):58–62.
   PubMed Web of Science ®Google Scholar
• Wang H, Yang S, Zhou H, et al. Aloperine executes antitumor effects against multiple myeloma through dual apoptotic mechanisms. J Hematol Oncol. 2015;8(1):26.
   PubMedGoogle Scholar
• Iinuma M, Ohyama M, Tanaka T. Six flavonostilbenes and a flavanone in roots of Sophora alopecuroides. Phytochemistry. 1995;38(2):519–525.
   Web of Science ®Google Scholar
• Wang H, Guo S, Qian D, et al. Comparative analysis of quinolizidine alkaloids from different parts of Sophora alopecuroides seeds by UPLC–MS/MS. J Pharm Biomed Anal. 2012;67:16–21.
   PubMed Web of Science ®Google Scholar
• Guo C, Yang L, Wan CX, et al. Anti-neuroinflammatory effect of sophoraflavanone G from Sophora alopecuroides in LPS-activated BV2 microglia by MAPK, JAK/STAT and Nrf2/HO-1 signaling pathways. Phytomedicine. 2016;23(13):1629–1637.
   PubMed Web of Science ®Google Scholar
• Ma S, Bai Z, Wu H, et al. The DPP-4 inhibitor saxagliptin ameliorates ox-LDL-induced endothelial dysfunction by regulating AP-1 and NF-κB. Eur J Pharmacol. 2019; 851:186–193.
   PubMed Web of Science ®Google Scholar
• Zhao J, Zhang G, Li M, et al. Neuro-protective effects of aloperine in an Alzheimer's disease cellular model. Biomed Pharmacother. 2018;108:137–143.
   PubMed Web of Science ®Google Scholar
• Lin Z, Kumar A, SenBanerjee S, et al. Kruppel-like factor 2 (KLF2) regulates endothelial thrombotic function. Circ Res. 2005; 96(5):e48–57.
   PubMed Web of Science ®Google Scholar
• Kumar A, Kim CS, Hoffman TA, et al. p53 Impairs endothelial function by transcriptionally repressing Kruppel-like factor 2. Arterioscler Thromb Vasc Biol. 2011;31(1):133–141.
   PubMed Web of Science ®Google Scholar
• Tolkachev ON, Monakhova TE, Sheichenko VI, et al. Alkaloids of a new type from Sophora alopecuroides L. Chem Nat Compd. 1975;11(1):29–34.
   Google Scholar
• Dang Z, Zhu L, Lai W, et al. Aloperine and its derivatives as a new class of HIV-1 entry inhibitors. ACS Med Chem Lett. 2016;7(3):240–244.
   PubMed Web of Science ®Google Scholar
• Zhang X, Lv XQ, Tang S, et al. Discovery and evolution of aloperine derivatives as a new family of HCV inhibitors with novel mechanism. Eur J Med Chem. 2018;143:1053–1065.
   PubMed Web of Science ®Google Scholar
• Ma NT, Zhou R, Chang RY, et al. Protective effects of aloperine on neonatal rat primary cultured hippocampal neurons injured by oxygen–glucose deprivation and reperfusion. J Nat Med. 2015;69(4):575–583.
   PubMed Web of Science ®Google Scholar
• Zhao J, Zhang G, Li M, et al. Neuro-protective effects of aloperine in an Alzheimer’s disease cellular model. Biomed Pharm. 2018;108:137–143.
   PubMed Web of Science ®Google Scholar
• Libby P, Rocha VZ. All roads lead to IL-6: a central hub of cardiometabolic signaling. Int J Cardiol. 2018;259:213–215.
   PubMed Web of Science ®Google Scholar
• Yuan XY, Liu W, Zhang P, et al. Effects and mechanisms of aloperine on 2, 4-dinitrofluorobenzene-induced allergic contact dermatitis in BALB/c mice. Eur J Pharmacol. 2010;629(1-3):147–152.
   PubMed Web of Science ®Google Scholar
• Hartmann P, Schober A, Weber C. Chemokines and microRNAs in atherosclerosis. Cell Mol Life Sci. 2015;72(17):3253–3266.
   PubMed Web of Science ®Google Scholar
• Chistiakov DA, Orekhov AN, Bobryshev YV. LOX-1-mediated effects on vascular cells in atherosclerosis. Cell Physiol Biochem. 2016;38(5):1851–1859.
   PubMedGoogle Scholar
• Childs BG, Baker DJ, Wijshake T, et al. Senescent intimal foam cells are deleterious at all stages of atherosclerosis. Science. 2016;354(6311):472–477.
   PubMed Web of Science ®Google Scholar
• Yang L, Liu J, Li Y, et al. Bornyl acetate suppresses ox-LDL-induced attachment of THP-1 monocytes to endothelial cells. Biomed Pharmacother. 2018;103:234–239.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Yang C, Dai X, et al. Inhibitory effect of trans-caryophyllene (TC) on leukocyte-endothelial attachment. Toxicol Appl Pharmacol. 2017;329:326–333.
   PubMed Web of Science ®Google Scholar
• Liu S, Pan S, Tan J, et al. Oxytocin inhibits ox-LDL-induced adhesion of monocytic THP-1 cells to human brain microvascular endothelial cells. Toxicol Appl Pharmacol. 2017;337:104–110.
   PubMed Web of Science ®Google Scholar
• Sathanoori R, Rosi F, Gu BJ, et al. Shear stress modulates endothelial KLF2 through activation of P2X4. Purinergic Signal. 2015;11(1):139–153.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Li H, Wang X. Lunasin abrogates monocytes to endothelial cells. Mol Immunol. 2017;92:146–150.
   PubMed Web of Science ®Google Scholar
• Xu Y, Xu S, Liu P, et al. Suberanilohydroxamic acid as a pharmacological Kruppel-like factor 2 activator that represses vascular inflammation and atherosclerosis. JAHA. 2017;6(12):e007134.
   Google Scholar